Hennion & Walsh Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $861K | Sell |
|
|||||
|
2025
Q2 | $774K | Sell |
|
|||||
|
2025
Q1 | $698K | Buy |
|
|||||
|
2024
Q4 | $705K | Sell |
|
|||||
|
2024
Q3 | $1.1M | Buy |
|
|||||
|
2024
Q2 | $929K | Sell |
|
|||||
|
2024
Q1 | $939K | Buy |
|
|||||
|
2023
Q4 | $784K | Sell |
|
|||||
|
2023
Q3 | $679K | Buy |
|
|||||
|
2023
Q2 | $528K | Buy |
|
|||||
|
2023
Q1 | $555K | Buy |
|
|||||
|
2022
Q4 | $544K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.24M | Buy |
|